TuisALM • BME
add
Almirall SA
Vorige sluiting
€11,26
Dagwisseling
€11,08 - €11,30
Jaarwisseling
€8,03 - €11,50
Markkapitalisasie
2,46 mjd EUR
Gemiddelde volume
119,84 k
P/V-verhouding
110,97
Dividend-opbrengs
1,65%
Primêre beurs
BME
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (EUR) | Jun. 2025info | J/J-verandering |
|---|---|---|
Inkomste | 277,27 m | 10,35% |
Bedryfskoste | 232,48 m | 12,88% |
Netto inkomste | 4,98 m | -37,68% |
Netto winsgrens | 1,80 | -43,40% |
Wins per aandeel | — | — |
EBITDA | 39,04 m | -25,03% |
Effektiewe belastingkoers | 40,20% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (EUR) | Jun. 2025info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 323,22 m | -2,31% |
Totale bates | 2,31 mjd | -0,58% |
Totale aanspreeklikheid | 844,82 m | 1,20% |
Totale ekwiteit | 1,46 mjd | — |
Uitstaande aandele | 214,79 m | — |
Prys om te bespreek | 1,65 | — |
Opbrengs op bates | 0,95% | — |
Opbrengs op kapitaal | 1,21% | — |
Kontantvloei
Netto kontantverandering
| (EUR) | Jun. 2025info | J/J-verandering |
|---|---|---|
Netto inkomste | 4,98 m | -37,68% |
Kontant van bedrywe | 31,15 m | -27,41% |
Kontant van beleggings | -58,13 m | 16,98% |
Kontant van finansiering | -24,47 m | -212,31% |
Netto kontantverandering | -51,45 m | -47,23% |
Beskikbare kontantvloei | -87,74 m | -11,43% |
Meer oor
Almirall, S.A. is a Spanish pharmaceutical company dedicated to medical dermatology, with headquarters in Barcelona, founded in 1944.
In 2023, the company generated total revenues of €898.8 million and was the leading European company in medical dermatology.
With approximately 1,904 employees, it has a direct presence in 20 countries through its 15 subsidiaries in Europe and the USA. Wikipedia
Gestig
1944
Webwerf
Werknemers
2 084
